A medical worker holds a syringe containing a flu vaccine at a mobile flu vaccination center in central Moscow. Centers.
Vyacheslav Prokofyev | TASS | Getty Images
Initial results from studies with Russia’s potential coronavirus vaccine show no serious negative side effects, a study published in the specialist journal The Lancet found on Friday.
“Preliminary results from Russian studies show that # COVID1
The doctors involved in the studies conducted “two open, non-randomized phase 1/2 studies in two hospitals in Russia” on 76 healthy volunteers aged 18 to 60, according to the Lancet article. It added that the vaccine formulations tested were “safe and well tolerated”.
The vaccine was called “Sputnik V” in Russia but has been criticized by the West because of questions about the speed of its approval and the lack of data.
However, Kirill Dmitriev, the head of the Russian sovereign wealth fund RDIF, which supports the vaccine, hailed the Lancet study as confirmation of his country’s efforts in an interview with CNBC.
“We were very interested in the publication of the Russian vaccine in the Lancet, one of the most important Western medicine magazines,” Dmitriev told CNBC’s Julianna Tatelbaum. “It is very important to share information with the world … the results were very good, but basically the study showed that both antibodies and the cells’ immune response are very strong.”
He added that Russia was “on track” to export the vaccine through November.
The Lancet is one of the oldest medical journals in the world, with editorial offices in New York, London and Beijing.
This is evolving news and will be updated shortly.